Formulation kit for liposomal doxorubicin composed of lyophilized liposomes

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 439-442

  Stevens, Phillip J ^a   Lee, Robert J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b College of Pharmacy ^*  (United States)

Author keywords

Cryoprotectant; Doxorubicin; Liposome; Lyophilization; Remote loading

Indexed keywords

CHOLESTEROL; CRYOPROTECTIVE AGENT; DOXORUBICIN; GLUCOSE; LIPOSOME; PHOSPHATIDYLCHOLINE; SUCROSE;

ARTICLE; DRUG FORMULATION; DRUG RETENTION; DRUG STABILITY; FREEZE DRYING; GEL FILTRATION CHROMATOGRAPHY; PARTICLE SIZE; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DOXORUBICIN; DRUG STABILITY; FREEZE DRYING; GLUCOSE; LIPOSOMES; PHOSPHATIDYLCHOLINES; SUCROSE;

EID: 0037235809     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Van Winden ECA, Zhang W and Crommelin DJA: Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration. Pharm Res 14(9): 1151-1160, 1997.
2. Suzuki T, Komatsu H and Miyajima K: Effects of glucose and its oligomers on the stability of freeze-dried liposomes. Biochim Biophys Acta 1278: 176-182, 1996.
3. Harasym TO, Cullis PR and Baly MB: Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes. Cancer Chemother Pharmacol 40: 309-317, 1997.
4. Tanaka K, Takeda T, Fuji K and Miyajima K: Cryoprotective mechanism of saccharides on freeze-drying of liposomes. Chem Pharm Bull 40(1): 1-5, 1992.
5. Tardi PG, Boman NL and Cullis PR: Liposomal doxorubicin. J Drug Target 43: 129-140, 1996.
6. Lee RJ and Low P: Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1233: 134-144, 1998.
7. Gou W, Lee T, Sudimack J and Lee RJ: Receptor-specific delivery of liposomes via folate-PEG-chol. J Liposome Res 10(2&3): 179-195, 2000.
8. Tanaka K, Takeda T, Fuijii K and Miyajima K: Freeze-drying of liposomes prepared by sonication and extrusion techniques. Chem Pharm Bull 39(10): 2653-2656, 1991.
9. Van Bommel ENG and Crommelin DJA: Stability of doxorubicin-liposomes on storage: as an aqueous dispersion, frozen or freeze-dried. Int J Pharm 22: 299-310, 1984.
10. Gabizon AA: Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Cancer Invest 19(4): 424-436, 2001.
11. Shaik MS, Ikodiobi O, Turnage VD, McSween J, Kanikkannan N and Singh M: Long-circulating monensis nanoparticles for the potentiation of immunotoxin and anticancer drugs. J Pharm Pharmacol 53(5): 617-627, 2001.
12. Peer D and Margalit R: Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposome. Arch Biochem Biophys 383(2): 185-190, 2000.
13. Miyajima K, Tomita K and Nakagaki M: Effect of Saccharides on the freezing and thawing of liposome dispersions. Chem Pharm Bull 34(7): 2689-2697, 1986.
14. Talsma H, Van Steenbergen MJ and Crommelin DJA: The cryopreservatin of liposomes: 3. Almost complete retention of a water-soluble marker in small liposomes in a cryoprotectant containing dispersion after freezing/thawing cycle. Int J Pharm Sci 77: 119-1126, 1991.
15. Cortesi R, Esposito E and Nastruzzi C: Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes. Antisense and Nucleic Acid Drug Development 10(3): 205-15, Jun 2000.
16. Li B, Li S, Tan Y, Stolz DB, Watkins SC, Block LH and Huang L: Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J Pharm Sci 89(3): 355-64, Mar 2000.